Wang Michael, Salek David, Belada David, Song Yuqin, Jurczak Wojciech, Kahl Brad S, . . . Borbényi Zita. (2025). Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma.
Chicago Style (17th ed.) CitationWang Michael, et al. Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma. 2025.
MLA idézésWang Michael, et al. Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma. 2025.
Figyelem: ezek az hivatkozások nem 100%-ban pontosak..